{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:26:07Z","timestamp":1791134767696,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Eukaryotic translation initiation factor eIF5A has been implicated in HIV-1 replication. This protein contains the apparently unique amino acid hypusine that is formed by the post-translational modification of a lysine residue catalyzed by deoxyhypusine synthase and deoxyhypusine hydroxylase (DOHH). DOHH activity is inhibited by two clinically used drugs, the topical fungicide ciclopirox and the systemic medicinal iron chelator deferiprone. Deferiprone has been reported to inhibit HIV-1 replication in tissue culture.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ciclopirox and deferiprone blocked HIV-1 replication in PBMCs. To examine the underlying mechanisms, we investigated the action of the drugs on eIF5A modification and HIV-1 gene expression in model systems. At early times after drug exposure, both drugs inhibited substrate binding to DOHH and prevented the formation of mature eIF5A. Viral gene expression from HIV-1 molecular clones was suppressed at the RNA level independently of all viral genes. The inhibition was specific for the viral promoter and occurred at the level of HIV-1 transcription initiation. Partial knockdown of eIF5A-1 by siRNA led to inhibition of HIV-1 gene expression that was non-additive with drug action. These data support the importance of eIF5A and hypusine formation in HIV-1 gene expression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>At clinically relevant concentrations, two widely used drugs blocked HIV-1 replication <jats:italic>ex vivo<\/jats:italic>. They specifically inhibited expression from the HIV-1 promoter at the level of transcription initiation. Both drugs interfered with the hydroxylation step in the hypusine modification of eIF5A. These results have profound implications for the potential therapeutic use of these drugs as antiretrovirals and for the development of optimized analogs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-4690-6-90","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T10:25:43Z","timestamp":1255515943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A"],"prefix":"10.1186","volume":"6","author":[{"given":"Mainul","family":"Hoque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut M","family":"Hanauske-Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene","family":"D'Alliessi Gandolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsafi","family":"Pe'ery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,13]]},"reference":[{"key":"1095_CR1","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMp0802028","volume":"358","author":"SW Lagakos","year":"2008","unstructured":"Lagakos SW, Gable AR: Challenges to HIV prevention--seeking effective measures in the absence of a vaccine. N Engl J Med. 2008, 358: 1543-1545. 10.1056\/NEJMp0802028.","journal-title":"N Engl J Med"},{"key":"1095_CR2","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1126\/science.280.5371.1880","volume":"280","author":"M Emerman","year":"1998","unstructured":"Emerman M, Malim MH: HIV-1 regulatory\/accessory genes: keys to unraveling viral and host cell biology. Science. 1998, 280: 1880-1884. 10.1126\/science.280.5371.1880.","journal-title":"Science"},{"key":"1095_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.antiviral.2006.01.002","volume":"71","author":"M Baba","year":"2006","unstructured":"Baba M: Recent status of HIV-1 gene expression inhibitors. Antiviral Res. 2006, 71: 301-306. 10.1016\/j.antiviral.2006.01.002.","journal-title":"Antiviral Res"},{"key":"1095_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/ncb1250","volume":"7","author":"A Lau","year":"2005","unstructured":"Lau A, Swinbank KM, Ahmed PS, Taylor DL, Jackson SP, Smith GC, O'Connor MJ: Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase. Nat Cell Biol. 2005, 7: 493-500. 10.1038\/ncb1250.","journal-title":"Nat Cell Biol"},{"key":"1095_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/geno.2000.6418","volume":"71","author":"ZA Jenkins","year":"2001","unstructured":"Jenkins ZA, Haag PG, Johansson HE: Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics. 2001, 71: 101-109. 10.1006\/geno.2000.6418.","journal-title":"Genomics"},{"key":"1095_CR6","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1046\/j.1432-1033.2003.03806.x","volume":"270","author":"PM Clement","year":"2003","unstructured":"Clement PM, Henderson CA, Jenkins ZA, Smit-McBride Z, Wolff EC, Hershey JW, Park MH, Johansson HE: Identification and characterization of eukaryotic initiation factor 5A-2. Eur J Biochem. 2003, 270: 4254-4263. 10.1046\/j.1432-1033.2003.03806.x.","journal-title":"Eur J Biochem"},{"key":"1095_CR7","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1083\/jcb.123.6.1309","volume":"123","author":"M Ruhl","year":"1993","unstructured":"Ruhl M, Himmelspach M, Bahr GM, Hammerschmid F, Jaksche H, Wolff B, Aschauer H, Farrington GK, Probst H, Bevec D, et al: Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J Cell Biol. 1993, 123: 1309-1320. 10.1083\/jcb.123.6.1309.","journal-title":"J Cell Biol"},{"key":"1095_CR8","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1126\/science.271.5257.1858","volume":"271","author":"D Bevec","year":"1996","unstructured":"Bevec D, Jaksche H, Oft M, Wohl T, Himmelspach M, Pacher A, Schebesta M, Koettnitz K, Dobrovnik M, Csonga R, et al: Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science. 1996, 271: 1858-1860. 10.1126\/science.271.5257.1858.","journal-title":"Science"},{"key":"1095_CR9","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1089\/hum.1996.7.15-1861","volume":"7","author":"U Junker","year":"1996","unstructured":"Junker U, Bevec D, Barske C, Kalfoglou C, Escaich S, Dobrovnik M, Hauber J, Bohnlein E: Intracellular expression of cellular eIF-5A mutants inhibits HIV-1 replication in human T cells: a feasibility study. Hum Gene Ther. 1996, 7: 1861-1869. 10.1089\/hum.1996.7.15-1861.","journal-title":"Hum Gene Ther"},{"key":"1095_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1172\/JCI200521949","volume":"115","author":"I Hauber","year":"2005","unstructured":"Hauber I, Bevec D, Heukeshoven J, Kratzer F, Horn F, Choidas A, Harrer T, Hauber J: Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest. 2005, 115: 76-85.","journal-title":"J Clin Invest"},{"key":"1095_CR11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0006-2952(98)00053-7","volume":"55","author":"L Andrus","year":"1998","unstructured":"Andrus L, Szabo P, Grady RW, Hanauske AR, Huima-Byron T, Slowinska B, Zagulska S, Hanauske-Abel HM: Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1). Biochem Pharmacol. 1998, 55: 1807-1818. 10.1016\/S0006-2952(98)00053-7.","journal-title":"Biochem Pharmacol"},{"key":"1095_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000109118","volume":"6","author":"D Bevec","year":"1997","unstructured":"Bevec D, Hauber J: Eukaryotic initiation factor 5A activity and HIV-1 Rev function. Biol Signals. 1997, 6: 124-133. 10.1159\/000109118.","journal-title":"Biol Signals"},{"issue":"Pt 14","key":"1095_CR13","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1242\/jcs.112.14.2369","volume":"112","author":"O Rosorius","year":"1999","unstructured":"Rosorius O, Reichart B, Kratzer F, Heger P, Dabauvalle MC, Hauber J: Nuclear pore localization and nucleocytoplasmic transport of eIF-5A: evidence for direct interaction with the export receptor CRM1. J Cell Sci. 1999, 112 (Pt 14): 2369-2380.","journal-title":"J Cell Sci"},{"key":"1095_CR14","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1073\/pnas.96.11.6229","volume":"96","author":"C Elfgang","year":"1999","unstructured":"Elfgang C, Rosorius O, Hofer L, Jaksche H, Hauber J, Bevec D: Evidence for specific nucleocytoplasmic transport pathways used by leucine-rich nuclear export signals. Proc Natl Acad Sci USA. 1999, 96: 6229-6234. 10.1073\/pnas.96.11.6229.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1095_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1083\/jcb.152.5.895","volume":"152","author":"W Hofmann","year":"2001","unstructured":"Hofmann W, Reichart B, Ewald A, Muller E, Schmitt I, Stauber RH, Lottspeich F, Jockusch BM, Scheer U, Hauber J, Dabauvalle MC: Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin. J Cell Biol. 2001, 152: 895-910. 10.1083\/jcb.152.5.895.","journal-title":"J Cell Biol"},{"key":"1095_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00726-007-0533-0","volume":"33","author":"CF Zanelli","year":"2007","unstructured":"Zanelli CF, Valentini SR: Is there a role for eIF5A in translation?. Amino Acids. 2007, 33: 351-358. 10.1007\/s00726-007-0533-0.","journal-title":"Amino Acids"},{"key":"1095_CR17","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bbrc.2006.07.195","volume":"348","author":"CF Zanelli","year":"2006","unstructured":"Zanelli CF, Maragno AL, Gregio AP, Komili S, Pandolfi JR, Mestriner CA, Lustri WR, Valentini SR: eIF5A binds to translational machinery components and affects translation in yeast. Biochem Biophys Res Commun. 2006, 348: 1358-1366. 10.1016\/j.bbrc.2006.07.195.","journal-title":"Biochem Biophys Res Commun"},{"key":"1095_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jcb.20658","volume":"97","author":"DL Jao","year":"2006","unstructured":"Jao DL, Chen KY: Tandem affinity purification revealed the hypusine-dependent binding of eukaryotic initiation factor 5A to the translating 80S ribosomal complex. J Cell Biochem. 2006, 97: 583-598. 10.1002\/jcb.20658.","journal-title":"J Cell Biochem"},{"key":"1095_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature08034","volume":"459","author":"P Saini","year":"2009","unstructured":"Saini P, Eyler DE, Green R, Dever TE: Hypusine-containing protein eIF5A promotes translation elongation. Nature. 2009, 459: 118-121. 10.1038\/nature08034.","journal-title":"Nature"},{"key":"1095_CR20","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1093\/emboj\/19.16.4362","volume":"19","author":"G Lipowsky","year":"2000","unstructured":"Lipowsky G, Bischoff FR, Schwarzmaier P, Kraft R, Kostka S, Hartmann E, Kutay U, Gorlich D: Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes. Embo J. 2000, 19: 4362-4371. 10.1093\/emboj\/19.16.4362.","journal-title":"Embo J"},{"key":"1095_CR21","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1093\/emboj\/17.10.2914","volume":"17","author":"D Zuk","year":"1998","unstructured":"Zuk D, Jacobson A: A single amino acid substitution in yeast eIF-5A results in mRNA stabilization. Embo J. 1998, 17: 2914-2925. 10.1093\/emboj\/17.10.2914.","journal-title":"Embo J"},{"key":"1095_CR22","doi-asserted-by":"publisher","first-page":"35336","DOI":"10.1074\/jbc.M601460200","volume":"281","author":"R Schrader","year":"2006","unstructured":"Schrader R, Young C, Kozian D, Hoffmann R, Lottspeich F: Temperature-sensitive eIF5A mutant accumulates transcripts targeted to the nonsense-mediated decay pathway. J Biol Chem. 2006, 281: 35336-35346. 10.1074\/jbc.M601460200.","journal-title":"J Biol Chem"},{"key":"1095_CR23","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/S0021-9258(17)40804-0","volume":"253","author":"R Benne","year":"1978","unstructured":"Benne R, Brown-Luedi ML, Hershey JW: Purification and characterization of protein synthesis initiation factors eIF-1, eIF-4C, eIF-4D, and eIF-5 from rabbit reticulocytes. J Biol Chem. 1978, 253: 3070-3077.","journal-title":"J Biol Chem"},{"key":"1095_CR24","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1073\/pnas.80.7.1854","volume":"80","author":"HL Cooper","year":"1983","unstructured":"Cooper HL, Park MH, Folk JE, Safer B, Braverman R: Identification of the hypusine-containing protein hy+ as translation initiation factor eIF-4D. Proc Natl Acad Sci USA. 1983, 80: 1854-1857. 10.1073\/pnas.80.7.1854.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1095_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000109123","volume":"6","author":"YP Liu","year":"1997","unstructured":"Liu YP, Nemeroff M, Yan YP, Chen KY: Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification. Biol Signals. 1997, 6: 166-174. 10.1159\/000109123.","journal-title":"Biol Signals"},{"key":"1095_CR26","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1074\/jbc.M008982200","volume":"276","author":"A Xu","year":"2001","unstructured":"Xu A, Chen KY: Hypusine is required for a sequence-specific interaction of eukaryotic initiation factor 5A with postsystematic evolution of ligands by exponential enrichment RNA. J Biol Chem. 2001, 276: 2555-2561. 10.1074\/jbc.M008982200.","journal-title":"J Biol Chem"},{"key":"1095_CR27","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1016\/S0021-9258(17)41723-6","volume":"269","author":"HA Kang","year":"1994","unstructured":"Kang HA, Hershey JW: Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J Biol Chem. 1994, 269: 3934-3940.","journal-title":"J Biol Chem"},{"key":"1095_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0014-5793(95)00493-S","volume":"366","author":"HM Hanauske-Abel","year":"1995","unstructured":"Hanauske-Abel HM, Slowinska B, Zagulska S, Wilson RC, Staiano-Coico L, Hanauske AR, McCaffrey T, Szabo P: Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary. Proposal of a role for eIF-5A in onset of DNA replication. FEBS Lett. 1995, 366: 92-98. 10.1016\/0014-5793(95)00493-S.","journal-title":"FEBS Lett"},{"key":"1095_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.yexcr.2006.09.030","volume":"313","author":"CA Taylor","year":"2007","unstructured":"Taylor CA, Sun Z, Cliche DO, Ming H, Eshaque B, Jin S, Hopkins MT, Thai B, Thompson JE: Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling. Exp Cell Res. 2007, 313: 437-449. 10.1016\/j.yexcr.2006.09.030.","journal-title":"Exp Cell Res"},{"key":"1095_CR30","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/j.1742-4658.2006.05135.x","volume":"273","author":"PM Clement","year":"2006","unstructured":"Clement PM, Johansson HE, Wolff EC, Park MH: Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. Febs J. 2006, 273: 1102-1114. 10.1111\/j.1742-4658.2006.05135.x.","journal-title":"Febs J"},{"key":"1095_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s007260170050","volume":"20","author":"M Caraglia","year":"2001","unstructured":"Caraglia M, Marra M, Giuberti G, D'Alessandro AM, Budillon A, del Prete S, Lentini A, Beninati S, Abbruzzese A: The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis. Amino Acids. 2001, 20: 91-104. 10.1007\/s007260170050.","journal-title":"Amino Acids"},{"key":"1095_CR32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.4161\/cbt.7.4.5478","volume":"7","author":"L Wei","year":"2007","unstructured":"Wei L, Wang Z, Cui T, Yi F, Bu Y, Ding S, Ma Y, Song F: Proteomic Analysis of Cervical Cancer Cells Treated with Adenovirus-Mediated MDA-7. Cancer Biol Ther. 2007, 7: 510-6.","journal-title":"Cancer Biol Ther"},{"key":"1095_CR33","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.0611609104","volume":"104","author":"Y Huang","year":"2007","unstructured":"Huang Y, Higginson DS, Hester L, Park MH, Snyder SH: Neuronal growth and survival mediated by eIF5A, a polyamine-modified translation initiation factor. Proc Natl Acad Sci USA. 2007, 104: 4194-4199. 10.1073\/pnas.0611609104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1095_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00438-005-0086-4","volume":"275","author":"I Chatterjee","year":"2006","unstructured":"Chatterjee I, Gross SR, Kinzy TG, Chen KY: Rapid depletion of mutant eukaryotic initiation factor 5A at restrictive temperature reveals connections to actin cytoskeleton and cell cycle progression. Mol Genet Genomics. 2006, 275: 264-276. 10.1007\/s00438-005-0086-4.","journal-title":"Mol Genet Genomics"},{"key":"1095_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ygyno.2004.03.018","volume":"94","author":"BM Cracchiolo","year":"2004","unstructured":"Cracchiolo BM, Heller DS, Clement PM, Wolff EC, Park MH, Hanauske-Abel HM: Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva. Gynecol Oncol. 2004, 94: 217-222. 10.1016\/j.ygyno.2004.03.018.","journal-title":"Gynecol Oncol"},{"key":"1095_CR36","first-page":"3806","volume":"61","author":"XY Guan","year":"2001","unstructured":"Guan XY, Sham JS, Tang TC, Fang Y, Huo KK, Yang JM: Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res. 2001, 61: 3806-3809.","journal-title":"Cancer Res"},{"key":"1095_CR37","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1158\/0008-5472.CAN-03-3747","volume":"64","author":"XY Guan","year":"2004","unstructured":"Guan XY, Fung JM, Ma NF, Lau SH, Tai LS, Xie D, Zhang Y, Hu L, Wu QL, Fang Y, Sham JS: Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res. 2004, 64: 4197-4200. 10.1158\/0008-5472.CAN-03-3747.","journal-title":"Cancer Res"},{"key":"1095_CR38","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1128\/MCB.11.6.3105","volume":"11","author":"J Schnier","year":"1991","unstructured":"Schnier J, Schwelberger HG, Smit-McBride Z, Kang HA, Hershey JW: Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. Mol Cell Biol. 1991, 11: 3105-3114.","journal-title":"Mol Cell Biol"},{"key":"1095_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1742-4658.2007.06172.x","volume":"275","author":"VS Cano","year":"2008","unstructured":"Cano VS, Jeon GA, Johansson HE, Henderson CA, Park JH, Valentini SR, Hershey JW, Park MH: Mutational analyses of human eIF5A-1--identification of amino acid residues critical for eIF5A activity and hypusine modification. Febs J. 2008, 275: 44-58.","journal-title":"Febs J"},{"key":"1095_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0167-4889(94)90003-5","volume":"1221","author":"HM Hanauske-Abel","year":"1994","unstructured":"Hanauske-Abel HM, Park MH, Hanauske AR, Popowicz AM, Lalande M, Folk JE: Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim Biophys Acta. 1994, 1221: 115-124. 10.1016\/0167-4889(94)90003-5.","journal-title":"Biochim Biophys Acta"},{"key":"1095_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ijc.10515","volume":"100","author":"PM Clement","year":"2002","unstructured":"Clement PM, Hanauske-Abel HM, Wolff EC, Kleinman HK, Park MH: The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro. Int J Cancer. 2002, 100: 491-498. 10.1002\/ijc.10515.","journal-title":"Int J Cancer"},{"key":"1095_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1023\/A:1016535217038","volume":"237","author":"Y Lee","year":"2002","unstructured":"Lee Y, Kim HK, Park HE, Park MH, Joe YA: Effect of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on endothelial cell growth, differentiation and apoptosis. Mol Cell Biochem. 2002, 237: 69-76. 10.1023\/A:1016535217038.","journal-title":"Mol Cell Biochem"},{"key":"1095_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1006\/excr.1999.4743","volume":"254","author":"G Wang","year":"2000","unstructured":"Wang G, Miskimins R, Miskimins WK: Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1). Exp Cell Res. 2000, 254: 64-71. 10.1006\/excr.1999.4743.","journal-title":"Exp Cell Res"},{"key":"1095_CR44","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1182\/blood-2005-03-037648","volume":"109","author":"S Balabanov","year":"2007","unstructured":"Balabanov S, Gontarewicz A, Ziegler P, Hartmann U, Kammer W, Copland M, Brassat U, Priemer M, Hauber I, Wilhelm T, et al: Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach. Blood. 2007, 109: 1701-1711. 10.1182\/blood-2005-03-037648.","journal-title":"Blood"},{"key":"1095_CR45","doi-asserted-by":"publisher","first-page":"14693","DOI":"10.1021\/bi00045a010","volume":"34","author":"H Klier","year":"1995","unstructured":"Klier H, Csonga R, Joao HC, Eckerskorn C, Auer M, Lottspeich F, Eder J: Isolation and structural characterization of different isoforms of the hypusine-containing protein eIF-5A from HeLa cells. Biochemistry. 1995, 34: 14693-14702. 10.1021\/bi00045a010.","journal-title":"Biochemistry"},{"key":"1095_CR46","doi-asserted-by":"publisher","first-page":"10745","DOI":"10.1074\/jbc.M709211200","volume":"283","author":"A Shirai","year":"2008","unstructured":"Shirai A, Matsuyama A, Yashiroda Y, Hashimoto A, Kawamura Y, Arai R, Komatsu Y, Horinouchi S, Yoshida M: Global analysis of gel mobility of proteins and its use in target identification. J Biol Chem. 2008, 283: 10745-10752. 10.1074\/jbc.M709211200.","journal-title":"J Biol Chem"},{"key":"1095_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jb\/mvj034","volume":"139","author":"MH Park","year":"2006","unstructured":"Park MH: The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A). J Biochem. 2006, 139: 161-169. 10.1093\/jb\/mvj034.","journal-title":"J Biochem"},{"key":"1095_CR48","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1073\/pnas.0710970105","volume":"105","author":"MK Chattopadhyay","year":"2008","unstructured":"Chattopadhyay MK, Park MH, Tabor H: Hypusine modification for growth is the major function of spermidine in Saccharomyces cerevisiae polyamine auxotrophs grown in limiting spermidine. Proc Natl Acad Sci USA. 2008, 105: 6554-6559. 10.1073\/pnas.0710970105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1095_CR49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00726-007-0525-0","volume":"33","author":"EC Wolff","year":"2007","unstructured":"Wolff EC, Kang KR, Kim YS, Park MH: Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification. Amino Acids. 2007, 33: 341-350. 10.1007\/s00726-007-0525-0.","journal-title":"Amino Acids"},{"key":"1095_CR50","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0304-4165(90)90024-Q","volume":"1036","author":"QP Dou","year":"1990","unstructured":"Dou QP, Chen KY: Characterization and reconstitution of a cell free system for NAD(+)-dependent deoxyhypusine formation on the 18 kDa eIF-4D precursor. Biochim Biophys Acta. 1990, 1036: 128-137.","journal-title":"Biochim Biophys Acta"},{"key":"1095_CR51","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1128\/MCB.22.11.3621-3632.2002","volume":"22","author":"YH Lee","year":"2002","unstructured":"Lee YH, Koh SS, Zhang X, Cheng X, Stallcup MR: Synergy among nuclear receptor coactivators: selective requirement for protein methyltransferase and acetyltransferase activities. Mol Cell Biol. 2002, 22: 3621-3632. 10.1128\/MCB.22.11.3621-3632.2002.","journal-title":"Mol Cell Biol"},{"key":"1095_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1073\/pnas.0509348102","volume":"103","author":"JH Park","year":"2006","unstructured":"Park JH, Aravind L, Wolff EC, Kaevel J, Kim YS, Park MH: Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme. Proc Natl Acad Sci USA. 2006, 103: 51-56. 10.1073\/pnas.0509348102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1095_CR53","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1083\/jcb.200904161","volume":"185","author":"PH Patel","year":"2009","unstructured":"Patel PH, Costa-Mattioli M, Schulze KL, Bellen HJ: The Drosophila deoxyhypusine hydroxylase homologue nero and its target eIF5A are required for cell growth and the regulation of autophagy. J Cell Biol. 2009, 185: 1181-1194. 10.1083\/jcb.200904161.","journal-title":"J Cell Biol"},{"key":"1095_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0167-4838(91)90053-3","volume":"1077","author":"A Abbruzzese","year":"1991","unstructured":"Abbruzzese A, Hanauske-Abel HM, Park MH, Henke S, Folk JE: The active site of deoxyhypusyl hydroxylase: use of catecholpeptides and their component chelator and peptide moieties as molecular probes. Biochim Biophys Acta. 1991, 1077: 159-166.","journal-title":"Biochim Biophys Acta"},{"key":"1095_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0014-5793(96)00020-8","volume":"380","author":"R Csonga","year":"1996","unstructured":"Csonga R, Ettmayer P, Auer M, Eckerskorn C, Eder J, Klier H: Evaluation of the metal ion requirement of the human deoxyhypusine hydroxylase from HeLa cells using a novel enzyme assay. FEBS Lett. 1996, 380: 209-214. 10.1016\/0014-5793(96)00020-8.","journal-title":"FEBS Lett"},{"issue":"Suppl 1","key":"1095_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1461-1244.2004.02380.x","volume":"43","author":"AK Gupta","year":"2004","unstructured":"Gupta AK, Plott T: Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties. Int J Dermatol. 2004, 43 (Suppl 1): 3-8. 10.1111\/j.1461-1244.2004.02380.x.","journal-title":"Int J Dermatol"},{"key":"1095_CR57","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2141.2006.05984.x","volume":"133","author":"JC Chan","year":"2006","unstructured":"Chan JC, Chim CS, Ooi CG, Cheung B, Liang R, Chan TK, Chan V: Use of the oral chelator deferiprone in the treatment of iron overload in patients with Hb H disease. Br J Haematol. 2006, 133: 198-205. 10.1111\/j.1365-2141.2006.05984.x.","journal-title":"Br J Haematol"},{"key":"1095_CR58","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1086\/315223","volume":"181","author":"NA Georgiou","year":"2000","unstructured":"Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ, van Asbeck BS: Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis. 2000, 181: 484-490. 10.1086\/315223.","journal-title":"J Infect Dis"},{"key":"1095_CR59","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s12098-007-0134-7","volume":"74","author":"VP Choudhry","year":"2007","unstructured":"Choudhry VP, Naithani R: Current status of iron overload and chelation with deferasirox. Indian J Pediatr. 2007, 74: 759-764. 10.1007\/s12098-007-0134-7.","journal-title":"Indian J Pediatr"},{"key":"1095_CR60","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0140-6736(91)92651-H","volume":"338","author":"JK Lazdins","year":"1991","unstructured":"Lazdins JK, Alteri E, Klimkait T, Woods-Cook K, Walker MR, Goutte G, Poncioni B: Lack of effect of desferrioxamine on in-vitro HIV-1 replication. Lancet. 1991, 338: 1341-1342. 10.1016\/0140-6736(91)92651-H.","journal-title":"Lancet"},{"issue":"Pt 1","key":"1095_CR61","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/bj3400273","volume":"340","author":"YB Lee","year":"1999","unstructured":"Lee YB, Joe YA, Wolff EC, Dimitriadis EK, Park MH: Complex formation between deoxyhypusine synthase and its protein substrate, the eukaryotic translation initiation factor 5A (eIF5A) precursor. Biochem J. 1999, 340 (Pt 1): 273-281. 10.1042\/0264-6021:3400273.","journal-title":"Biochem J"},{"key":"1095_CR62","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0014-5793(03)01305-X","volume":"555","author":"GM Thompson","year":"2003","unstructured":"Thompson GM, Cano VS, Valentini SR: Mapping eIF5A binding sites for Dys1 and Lia1: in vivo evidence for regulation of eIF5A hypusination. FEBS Lett. 2003, 555: 464-468. 10.1016\/S0014-5793(03)01305-X.","journal-title":"FEBS Lett"},{"key":"1095_CR63","doi-asserted-by":"publisher","first-page":"8300","DOI":"10.1074\/jbc.M607495200","volume":"282","author":"KR Kang","year":"2007","unstructured":"Kang KR, Kim YS, Wolff EC, Park MH: Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A. J Biol Chem. 2007, 282: 8300-8308. 10.1074\/jbc.M607495200.","journal-title":"J Biol Chem"},{"key":"1095_CR64","doi-asserted-by":"crossref","first-page":"13151","DOI":"10.1016\/S0021-9258(19)38631-4","volume":"268","author":"J Jakus","year":"1993","unstructured":"Jakus J, Wolff EC, Park MH, Folk JE: Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. Effective inhibition by bis- and mono-guanylated diamines and polyamines. J Biol Chem. 1993, 268: 13151-13159.","journal-title":"J Biol Chem"},{"key":"1095_CR65","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.1074\/jbc.M404095200","volume":"279","author":"TC Umland","year":"2004","unstructured":"Umland TC, Wolff EC, Park MH, Davies DR: A new crystal structure of deoxyhypusine synthase reveals the configuration of the active enzyme and of an enzyme.NAD.inhibitor ternary complex. J Biol Chem. 2004, 279: 28697-28705. 10.1074\/jbc.M404095200.","journal-title":"J Biol Chem"},{"key":"1095_CR66","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/ncb1000","volume":"5","author":"YH Zheng","year":"2003","unstructured":"Zheng YH, Yu HF, Peterlin BM: Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nat Cell Biol. 2003, 5: 611-618. 10.1038\/ncb1000.","journal-title":"Nat Cell Biol"},{"key":"1095_CR67","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1126\/science.3277284","volume":"239","author":"MR Sadaie","year":"1988","unstructured":"Sadaie MR, Benter T, Wong-Staal F: Site-directed mutagenesis of two trans-regulatory genes (tat-III, trs) of HIV-1. Science. 1988, 239: 910-913. 10.1126\/science.3277284.","journal-title":"Science"},{"key":"1095_CR68","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1101\/gad.11.20.2622","volume":"11","author":"Y Zhu","year":"1997","unstructured":"Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH: Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 1997, 11: 2622-2632. 10.1101\/gad.11.20.2622.","journal-title":"Genes Dev"},{"key":"1095_CR69","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/330489a0","volume":"330","author":"SY Kao","year":"1987","unstructured":"Kao SY, Calman AF, Luciw PA, Peterlin BM: Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (London). 1987, 330: 489-493. 10.1038\/330489a0.","journal-title":"Nature (London)"},{"key":"1095_CR70","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0092-8674(89)90290-0","volume":"59","author":"MF Laspia","year":"1989","unstructured":"Laspia MF, Rice AP, Mathews MB: HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell. 1989, 59: 283-292. 10.1016\/0092-8674(89)90290-0.","journal-title":"Cell"},{"key":"1095_CR71","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1042\/BJ20041477","volume":"385","author":"K Nishimura","year":"2005","unstructured":"Nishimura K, Murozumi K, Shirahata A, Park MH, Kashiwagi K, Igarashi K: Independent roles of eIF5A and polyamines in cell proliferation. Biochem J. 2005, 385: 779-785. 10.1042\/BJ20041477.","journal-title":"Biochem J"},{"key":"1095_CR72","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1086\/507043","volume":"194","author":"B Schafer","year":"2006","unstructured":"Schafer B, Hauber I, Bunk A, Heukeshoven J, Dusedau A, Bevec D, Hauber J: Inhibition of multidrug-resistant HIV-1 by interference with cellular S-adenosylmethionine decarboxylase activity. J Infect Dis. 2006, 194: 740-750. 10.1086\/507043.","journal-title":"J Infect Dis"},{"key":"1095_CR73","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/BF02255534","volume":"3","author":"PK Chiang","year":"1996","unstructured":"Chiang PK, McCann PP, Lane JR, Pankaskie MC, Burke DS, Mayers DL: Antihuman Immunodeficiency Virus (HIV-1) Activities of Inhibitors of Polyamine Pathways. J Biomed Sci. 1996, 3: 78-81. 10.1007\/BF02255534.","journal-title":"J Biomed Sci"},{"key":"1095_CR74","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1021\/jm0201621","volume":"45","author":"CJ Marasco Jr","year":"2002","unstructured":"Marasco CJ, Kramer DL, Miller J, Porter CW, Bacchi CJ, Rattendi D, Kucera L, Iyer N, Bernacki R, Pera P, Sufrin JR: Synthesis and evaluation of analogues of 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine as inhibitors of tumor cell growth, trypanosomal growth, and HIV-1 infectivity. J Med Chem. 2002, 45: 5112-5122. 10.1021\/jm0201621.","journal-title":"J Med Chem"},{"key":"1095_CR75","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/viro.2002.1659","volume":"304","author":"RA Hart","year":"2002","unstructured":"Hart RA, Billaud JN, Choi SJ, Phillips TR: Effects of 1,8-diaminooctane on the FIV Rev regulatory system. Virology. 2002, 304: 97-104. 10.1006\/viro.2002.1659.","journal-title":"Virology"},{"key":"1095_CR76","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/clpt.1990.147","volume":"48","author":"GJ Kontoghiorghes","year":"1990","unstructured":"Kontoghiorghes GJ, Goddard JG, Bartlett AN, Sheppard L: Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Clin Pharmacol Ther. 1990, 48: 255-261. 10.1038\/clpt.1990.147.","journal-title":"Clin Pharmacol Ther"},{"key":"1095_CR77","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1046\/j.1365-4362.2001.01156.x","volume":"40","author":"AK Gupta","year":"2001","unstructured":"Gupta AK: Ciclopirox: an overview. Int J Dermatol. 2001, 40: 305-310. 10.1046\/j.1365-4362.2001.01156.x.","journal-title":"Int J Dermatol"},{"key":"1095_CR78","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00042560-199808150-00009","volume":"18","author":"Y Salhi","year":"1998","unstructured":"Salhi Y, Costagliola D, Rebulla P, Dessi C, Karagiorga M, Lena-Russo D, de Montalembert M, Girot R: Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 18: 473-478.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"1095_CR79","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.virol.2007.06.011","volume":"367","author":"Z Debebe","year":"2007","unstructured":"Debebe Z, Ammosova T, Jerebtsova M, Kurantsin-Mills J, Niu X, Charles S, Richardson DR, Ray PE, Gordeuk VR, Nekhai S: Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Virology. 2007, 367: 324-333. 10.1016\/j.virol.2007.06.011.","journal-title":"Virology"},{"key":"1095_CR80","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1089\/aid.1995.11.1049","volume":"11","author":"C Sappey","year":"1995","unstructured":"Sappey C, Boelaert JR, Legrand-Poels S, Forceille C, Favier A, Piette J: Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res Hum Retroviruses. 1995, 11: 1049-1061. 10.1089\/aid.1995.11.1049.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1095_CR81","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1386-6532(00)00122-0","volume":"20","author":"BS van Asbeck","year":"2001","unstructured":"van Asbeck BS, Georgiou NA, Bruggen van der T, Oudshoorn M, Nottet HS, Marx JJ: Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol. 2001, 20: 141-147. 10.1016\/S1386-6532(00)00122-0.","journal-title":"J Clin Virol"},{"issue":"Suppl 1","key":"1095_CR82","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1365-2362.2002.0320s1091.x","volume":"32","author":"NA Georgiou","year":"2002","unstructured":"Georgiou NA, Bruggen van der T, Oudshoorn M, Hider RC, Marx JJ, van Asbeck BS: Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis. Eur J Clin Invest. 2002, 32 (Suppl 1): 91-96. 10.1046\/j.1365-2362.2002.0320s1091.x.","journal-title":"Eur J Clin Invest"},{"key":"1095_CR83","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2174\/0929867033457610","volume":"10","author":"H Nick","year":"2003","unstructured":"Nick H, Acklin P, Lattmann R, Buehlmayer P, Hauffe S, Schupp J, Alberti D: Development of tridentate iron chelators: from desferrithiocin to ICL670. Curr Med Chem. 2003, 10: 1065-1076. 10.2174\/0929867033457610.","journal-title":"Curr Med Chem"},{"key":"1095_CR84","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0167-4838(98)00109-5","volume":"1387","author":"Y Li","year":"1998","unstructured":"Li Y, Harris WR: Iron removal from monoferric human serum transferrins by 1, 2-dimethyl-3-hydroxypyridin-4-one, 1-hydroxypyridin-2-one and acetohydroxamic acid. Biochim Biophys Acta. 1998, 1387: 89-102.","journal-title":"Biochim Biophys Acta"},{"key":"1095_CR85","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0014-5793(89)80201-7","volume":"245","author":"MA Barradas","year":"1989","unstructured":"Barradas MA, Jeremy JY, Kontoghiorghes GJ, Mikhailidis DP, Hoffbrand AV, Dandona P: Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity. FEBS Lett. 1989, 245: 105-109. 10.1016\/0014-5793(89)80201-7.","journal-title":"FEBS Lett"},{"key":"1095_CR86","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0014-5793(85)80859-0","volume":"189","author":"GJ Kontoghiorghes","year":"1985","unstructured":"Kontoghiorghes GJ, Evans RW: Site specificity of iron removal from transferrin by alpha-ketohydroxypyridine chelators. FEBS Lett. 1985, 189: 141-144. 10.1016\/0014-5793(85)80859-0.","journal-title":"FEBS Lett"},{"key":"1095_CR87","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2165\/00002018-200326090-00002","volume":"26","author":"J Lisziewicz","year":"2003","unstructured":"Lisziewicz J, Foli A, Wainberg M, Lori F: Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns. Drug Saf. 2003, 26: 605-624. 10.2165\/00002018-200326090-00002.","journal-title":"Drug Saf"},{"key":"1095_CR88","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00002030-200301030-00007","volume":"17","author":"F Garcia","year":"2003","unstructured":"Garcia F, Plana M, Arnedo M, Ortiz GM, Miro JM, Lopalco L, Lori F, Pumarola T, Gallart T, Gatell JM: A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study. AIDS. 2003, 17: 43-51. 10.1097\/00002030-200301030-00007.","journal-title":"AIDS"},{"key":"1095_CR89","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1365-2249.2000.01203.x","volume":"120","author":"MA Calzado","year":"2000","unstructured":"Calzado MA, MacHo A, Lucena C, Munoz E: Hydroxyurea inhibits the transactivation of the HIV-long-terminal repeat (LTR) promoter. Clin Exp Immunol. 2000, 120: 317-323. 10.1046\/j.1365-2249.2000.01203.x.","journal-title":"Clin Exp Immunol"},{"key":"1095_CR90","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1128\/JVI.73.7.5422-5430.1999","volume":"73","author":"S Gummuluru","year":"1999","unstructured":"Gummuluru S, Emerman M: Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines. J Virol. 1999, 73: 5422-5430.","journal-title":"J Virol"},{"key":"1095_CR91","doi-asserted-by":"publisher","first-page":"7266","DOI":"10.1128\/JVI.75.16.7266-7279.2001","volume":"75","author":"D Wang","year":"2001","unstructured":"Wang D, de la Fuente C, Deng L, Wang L, Zilberman I, Eadie C, Healey M, Stein D, Denny T, Harrison LE, et al: Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors. J Virol. 2001, 75: 7266-7279. 10.1128\/JVI.75.16.7266-7279.2001.","journal-title":"J Virol"},{"key":"1095_CR92","doi-asserted-by":"publisher","first-page":"12198","DOI":"10.1128\/JVI.78.22.12198-12206.2004","volume":"78","author":"S Thierry","year":"2004","unstructured":"Thierry S, Marechal V, Rosenzwajg M, Sabbah M, Redeuilh G, Nicolas JC, Gozlan J: Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter. J Virol. 2004, 78: 12198-12206. 10.1128\/JVI.78.22.12198-12206.2004.","journal-title":"J Virol"},{"key":"1095_CR93","doi-asserted-by":"publisher","first-page":"8130","DOI":"10.1074\/jbc.273.14.8130","volume":"273","author":"M Kundu","year":"1998","unstructured":"Kundu M, Sharma S, De Luca A, Giordano A, Rappaport J, Khalili K, Amini S: HIV-1 Tat elongates the G1 phase and indirectly promotes HIV-1 gene expression in cells of glial origin. J Biol Chem. 1998, 273: 8130-8136. 10.1074\/jbc.273.14.8130.","journal-title":"J Biol Chem"},{"key":"1095_CR94","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/jvi.68.2.654-660.1994","volume":"68","author":"BK Chen","year":"1994","unstructured":"Chen BK, Saksela K, Andino R, Baltimore D: Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J Virol. 1994, 68: 654-660.","journal-title":"J Virol"},{"key":"1095_CR95","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1128\/MCB.23.18.6373-6384.2003","volume":"23","author":"TM Young","year":"2003","unstructured":"Young TM, Wang Q, Pe'ery T, Mathews MB: The Human I-mfa Domain-Containing Protein, HIC, Interacts with Cyclin T1 and Modulates P-TEFb-Dependent Transcription. Mol Cell Biol. 2003, 23: 6373-6384. 10.1128\/MCB.23.18.6373-6384.2003.","journal-title":"Mol Cell Biol"},{"key":"1095_CR96","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1128\/MCB.23.5.1688-1702.2003","volume":"23","author":"M Hoque","year":"2003","unstructured":"Hoque M, Young TM, Lee CG, Serrero G, Mathews MB, Pe'ery T: The Growth Factor Granulin Interacts with Cyclin T1 and Modulates P-TEFb-Defendent Transcription. Mol Cell Biol. 2003, 23: 1688-1702. 10.1128\/MCB.23.5.1688-1702.2003.","journal-title":"Mol Cell Biol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-6-90.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:17:56Z","timestamp":1630480676000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-6-90"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,13]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1095"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-6-90","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,13]]},"assertion":[{"value":"6 March 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"90"}}